Showing results (41-50 of 74) with videos related to
Sort By:
Pageof 8
British Journal of Cancer|March 27, 2014
Identification of high-risk patients with clear cell renal cell carcinoma based on interphase-FISHJ Sanjmyatav, S Matthes, M Muehr, et al.Physiologia Plantarum|March 16, 2022
Defects in meristem maintenance, cell division, and cytokinin signaling are early responses in the boron deficient maize mutant tassel-less1Michaela S Matthes, Zoe Darnell, Norman B Best, et al.Leukemia|December 22, 1999
Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejectionJ Dubovsky, H Daxberger, G Fritsch, et al.Annals of Hematology|April 23, 2013
Ferritin concentrations correlate to outcome of hematopoietic stem cell transplantation but do not serve as biomarker of graft-versus-host diseaseM Großekatthöfer, E D Güclü, A Lawitschka, et al.Bone Marrow Transplantation|May 7, 2003
Pre-emptive treatment of CMV DNAemia in paediatric stem cell transplantation: the impact of recipient and donor CMV serostatus on the incidence of CMV disease and CMV-related mortalityS Matthes-Martin, T Lion, S W Aberle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Acute encephalopathy: a new toxicity associated with high-dose paclitaxelY Nieto, P J Cagnoni, S I Bearman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 1999
Nonpredictable pharmacokinetic behavior of high-dose cyclophosphamide in combination with cisplatin and 1,3-bis(2-chloroethyl)-1-nitrosoureaY Nieto, X Xu, P J Cagnoni, et al.Cytotherapy|April 30, 2010
Flow cytometric monitoring of hematopoietic reconstitution in myeloablated patients following allogeneic transplantationG Fritsch, V Witt, J Dubovsky, et al.Haematologica|April 5, 2007
Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosisM Steiner, S Matthes-Martin, A Attarbaschi, et al.Journal of the National Cancer Institute|April 21, 1993
Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustineR B Jones, S Matthes, E J Shpall, et al.Pageof 8